Close Menu
The Business TimesThe Business Times
  • Home
  • News
  • Business
  • Finance
  • Economy
  • Markets
  • Investing
  • Real Estate
  • Crypto
  • Fintech
  • Forex
  • More
    • Politics
    • Web Stories
    • Spotlight
    • Press Release
What's On

Rapsodo and GCMA support the next generation of UK golf practice facilities

15 October 2026

flyExclusive Stock: Sell Despite Strong Turnaround (NYSE:FLYX)

15 October 2026

Gecina 2026 Q3 – Results – Earnings Call Presentation (OTCMKTS:GECFF) 2026-10-15

15 October 2026

AriBio, Fosun, And Alzheimer’s Disease: Close, But Perhaps Not Enough (OTCMKTS:SFOSF)

15 October 2026

Procore: Priced For The Resilient Slump, Levered For The Non Residential Recovery (PCOR)

15 October 2026
Facebook X (Twitter) Instagram
Business Thursday, Oct 15
The Business TimesThe Business Times
Newsletter
  • Home
  • News
  • Business
  • Finance
  • Economy
  • Markets
  • Investing
  • Real Estate
  • Crypto
  • Fintech
  • Forex
  • More
    • Politics
    • Web Stories
    • Spotlight
    • Press Release
The Business TimesThe Business Times
Home » Mark Gatiss reveals physical toll of playing post-war detective in hit series Bookish
News

Mark Gatiss reveals physical toll of playing post-war detective in hit series Bookish

thebusinesstimes.co.ukBy thebusinesstimes.co.uk20 August 20266 Views
Facebook Twitter LinkedIn Reddit Telegram WhatsApp Pinterest Tumblr VKontakte Email
Share
Facebook Twitter LinkedIn Pinterest Email

Sherlock co-creator Mark Gatiss is back on solving crimes in post-war London as hit detective drama Bookish returns for a second series. Speaking ahead of the new run, the 59-year-old actor and co-writer Matthew Sweet open up about crafting twisty murder plots and why playing an athletic sleuth leaves Mark’s knees "going off like pistol shots"

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email Reddit Telegram WhatsApp

Related Articles

flyExclusive Stock: Sell Despite Strong Turnaround (NYSE:FLYX)

Gecina 2026 Q3 – Results – Earnings Call Presentation (OTCMKTS:GECFF) 2026-10-15

AriBio, Fosun, And Alzheimer’s Disease: Close, But Perhaps Not Enough (OTCMKTS:SFOSF)

Procore: Priced For The Resilient Slump, Levered For The Non Residential Recovery (PCOR)

TOYO: Investor Pessimism Justified – Hold Until December’s Commerce Ruling (NASDAQ:TOYO)

West Wits Mining Limited (WMWWF) Shareholder/Analyst Call Transcript

Meta Stock: The Muse Rally Has Priced In The Good News Before Q3 (NASDAQ:META)

Comtech Telecommunications Corp. (CMTL) Q4 2026 Earnings Call Transcript

Bank of Queensland Limited 2026 Q4 – Results – Earnings Call Presentation (OTCMKTS:BKQNY) 2026-10-14

Editors Picks

flyExclusive Stock: Sell Despite Strong Turnaround (NYSE:FLYX)

15 October 2026

Gecina 2026 Q3 – Results – Earnings Call Presentation (OTCMKTS:GECFF) 2026-10-15

15 October 2026

AriBio, Fosun, And Alzheimer’s Disease: Close, But Perhaps Not Enough (OTCMKTS:SFOSF)

15 October 2026

Procore: Priced For The Resilient Slump, Levered For The Non Residential Recovery (PCOR)

15 October 2026

Subscribe to News

Get the latest finance and business news and updates directly to your inbox.

Latest Posts

TOYO: Investor Pessimism Justified – Hold Until December’s Commerce Ruling (NASDAQ:TOYO)

15 October 2026

West Wits Mining Limited (WMWWF) Shareholder/Analyst Call Transcript

15 October 2026

Meta Stock: The Muse Rally Has Priced In The Good News Before Q3 (NASDAQ:META)

15 October 2026
Facebook X (Twitter) Pinterest WhatsApp TikTok Instagram
© 2026 The Business Times. All Rights Reserved.
  • Privacy Policy
  • Terms
  • Advertise
  • Contact

Type above and press Enter to search. Press Esc to cancel.